You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
冠昊生物(300238.SZ)參股公司ZY公司獲得一項發明專利證書
格隆匯 12-19 17:51

格隆匯12月19日丨冠昊生物(300238.SZ)公佈,公司的參股公司ZY Therapeutics Inc.(“ZY公司”)於近期收到美國國家知識產權局頒發的一項《發明專利證書》,專利名稱為DRUG FO RMULATION BASED ON PARTICULATES COMPRISING POLYSACCHARIDE-VITAMIN CONJUGATE

ZY Therapeutics Inc.2015915日設立,是一家生物醫藥技術公司,公司註冊地位於美國北卡羅萊納州,主營開發並市場化創新的納米靶向藥物傳送平台、創新型紫杉醇多糖載體腫瘤新藥、紫杉醇白蛋白結合型改良針劑等。該項發明專利提供了創新型用於包埋活性藥物的製劑平台技術,包括如何將疏水性活性藥物(例如抗癌藥)封裝在多糖聚合物中,最後製成凍乾粉針劑給予病人使用。與其他納米包埋技術不同的是,該納米制劑的活性藥物在顆粒的核心部分,而不是在納米顆粒的表面上。本專利公開了製備和使用納米載藥顆粒的方法以及成分,特別地公開了該技術在癌症診斷和治療的應用。

上述美國發明專利的取得ZY公司目前進行中的歐洲、加拿大、日本等國專利申請提供非常有力的支持。該專利證書的獲得,有利於保護ZY公司全球知識產權,提升ZY公司核心競爭能力,對ZY公司業務產生積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account